Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Telos
TLS
$341M
| $2.02M | ﹤0.01% |
59,435
+58,343
| +5,343% | +$1.96M |
|
|
GAP
2627
CALL
The Gap Inc
GAP
$7.24B
| $2.02M | ﹤0.01% |
60,000
| – | – |
|
|
ITCI
2628
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.01M | ﹤0.01% |
49,349
+16,046
| +48% | +$593K |
|
2629
iShares Russell Top 200 Value ETF
IWX
$4.01B
| $2.01M | ﹤0.01% |
30,300
-8,065
| -21% | -$535K |
|
|
NXRT
2630
NexPoint Residential Trust
NXRT
$668M
| $2.01M | ﹤0.01% |
36,546
+11,451
| +46% | +$589K |
|
|
HERAU
2631
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
| $2.01M | ﹤0.01% |
200,000
| – | – |
|
2632
Global X Lithium & Battery Tech ETF
LIT
$1.5B
| $2.01M | ﹤0.01% |
27,690
-25,766
| -48% | -$1.66M |
|
2633
America Movil
AMX
$75.4B
| $2M | ﹤0.01% |
133,607
+1,910
| +1% | +$28.4K |
|
2634
Enpro
NPO
$6.83B
| $2M | ﹤0.01% |
20,634
+8,997
| +77% | +$822K |
|
2635
iShares MSCI India ETF
INDA
$6.6B
| $2M | ﹤0.01% |
45,239
-5,263
| -10% | -$226K |
|
|
CVIIU
2636
DELISTED
Churchill Capital Corp VII Units
CVIIU
| $2M | ﹤0.01% |
200,000
-50,000
| -20% | -$502K |
|
2637
Alto Ingredients
ALTO
$373M
| $2M | ﹤0.01% |
327,204
-73,932
| -18% | -$430K |
|
2638
Mueller Industries
MLI
$14.6B
| $2M | ﹤0.01% |
184,540
+105,092
| +132% | +$1.19M |
|
2639
Donaldson
DCI
$11B
| $2M | ﹤0.01% |
31,441
+161
| +0.5% | +$9.95K |
|
2640
Anika Therapeutics
ANIK
$275M
| $2M | ﹤0.01% |
46,078
+4,330
| +10% | +$184K |
|
2641
Invesco WilderHill Clean Energy ETF
PBW
$408M
| $1.99M | ﹤0.01% |
21,335
+5,365
| +34% | +$465K |
|
2642
AnaptysBio
ANAB
$1.57B
| $1.99M | ﹤0.01% |
76,578
-37,574
| -33% | -$901K |
|
|
ZIXI
2643
DELISTED
Zix Corporation
ZIXI
| $1.98M | ﹤0.01% |
281,176
+28,266
| +11% | +$205K |
|
|
NGM
2644
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.98M | ﹤0.01% |
100,318
+95,997
| +2,222% | +$2.25M |
|
2645
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $1.98M | ﹤0.01% |
34,347
-97,537
| -74% | -$5.6M |
|
2646
Sonoco
SON
$5.57B
| $1.97M | ﹤0.01% |
29,412
+385
| +1% | +$25.6K |
|
2647
Simpson Manufacturing
SSD
$7.84B
| $1.97M | ﹤0.01% |
17,807
-1,093
| -6% | -$121K |
|
2648
AngloGold Ashanti
AU
$41.9B
| $1.96M | ﹤0.01% |
105,623
-461,808
| -81% | -$10.2M |
|
2649
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
| $1.96M | ﹤0.01% |
24,243
-949
| -4% | -$76.2K |
|
2650
Axos Financial
AX
$5.87B
| $1.96M | ﹤0.01% |
42,280
+23,323
| +123% | +$1.09M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.